Opus Genetics, Inc. (IRD)

4.26 -0.03 (-0.70%) USD  |  NASDAQ  |  May 22, 16:00
4.275 +0.02 (+0.35%) After-Hours: 20:00
More

Opus Genetics EBITDA (Quarterly)

EBITDA (Quarterly) Chart

View EBITDA (Quarterly) for IRD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Quarterly) Range, Past 5 Years

View EBITDA (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Quarterly) Benchmarks

View EBITDA (Quarterly) Benchmarks
Start Trial
Keros Therapeutics, Inc. Upgrade
Xilio Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Amgen, Inc. Upgrade